Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. 908 Devices Inc.
  6. Summary
    MASS   US65443P1021

908 DEVICES INC.

(MASS)
  Report
Real-time Estimate Quote. Real-time Estimate Cboe BZX - 12/07 02:08:00 pm
28.38 USD   +15.60%
11/11908 Devices to Participate in Upcoming Investor Conferences
BU
11/10908 Devices Announces Pricing of Public Offering
BU
11/09908 Devices Launches Offering of 2.75 Million Common Shares
MT
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
12/01/2021 12/02/2021 12/03/2021 12/06/2021 12/07/2021 Date
24(c) 24.32(c) 23.17(c) 24.55(c) 28.28 Last
434 306 291 967 469 074 326 327 266 752 Volume
0.00% +1.33% -4.73% +5.96% +15.19% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 41,5 M - -
Net income 2021 -20,5 M - -
Net Debt 2021 - - -
P/E ratio 2021 -30,5x
Yield 2021 -
Sales 2022 53,9 M - -
Net income 2022 -18,5 M - -
Net Debt 2022 - - -
P/E ratio 2022 -29,6x
Yield 2022 -
Capitalization 685 M 685 M -
Capi. / Sales 2021 16,5x
Capi. / Sales 2022 12,7x
Nbr of Employees 101
Free-Float 73,5%
More Financials
Company
908 Devices Inc. offers a suite of purpose-built handheld and desktop mass spectrometry (Mass Spec) devices for the point-of-need. The Company's Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide answers to address problems in life sciences research, bioprocessing, industrial biotechnology, forensics and adjacent markets. Its products include MX908, Rebel and... 
More about the company
Ratings of 908 Devices Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C-
More Ratings
All news about 908 DEVICES INC.
11/11908 Devices to Participate in Upcoming Investor Conferences
BU
11/10908 Devices Announces Pricing of Public Offering
BU
11/09908 Devices Launches Offering of 2.75 Million Common Shares
MT
11/08908 Devices to Seek Acquisitions
CI
11/08908 Devices Announces Launch of Public Offering
BU
11/05INSIDER SELL : 908 Devices
MT
11/04908 Devices Q3 Net Loss, Share Count Increase as Sales Surge; Tightens 2021 Revenue Gui..
MT
11/04908 DEVICES INC. Management's Discussion and Analysis of Financial Condition and Resul..
AQ
11/04908 Devices Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended S..
CI
11/04Devices Reports Third Quarter 2021 Financial Results - Form 8-K
PU
11/04Earnings Flash (MASS) 908 DEVICES Posts Q3 Revenue $12.5M, vs. Street Est of $12M
MT
11/04908 Devices Reports Third Quarter 2021 Financial Results
BU
11/04908 Devices Inc. Provides Revenue Guidance for the Full Year 2021
CI
11/02INSIDER SELL : 908 Devices
MT
11/01908 Devices Launches Oligos Kit for its ZipChip CE-MS Device
BU
More news
News in other languages on 908 DEVICES INC.
11/09908 Devices lance une offre de 2,75 millions d'actions ordinaires
11/05VENTE PAR UN INITIÉ : 908 Devices
11/04La perte nette et le nombre d'actions de 908 Devices augmentent au troisième trimestre ..
11/04Earnings Flash (MASS) 908 DEVICES affiche un chiffre d'affaires de 12,5 millions de dol..
11/04908 Devices Inc. fournit des prévisions de revenus pour l'ensemble de l'année 2021
More news
Analyst Recommendations on 908 DEVICES INC.
More recommendations
Chart 908 DEVICES INC.
Duration : Period :
908 Devices Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends 908 DEVICES INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 24,55 $
Average target price 55,00 $
Spread / Average Target 124%
EPS Revisions
Managers and Directors
Kevin J. Knopp President, Chief Executive Officer & Director
Joseph H. Griffith Chief Financial Officer
E. Kevin Hrusovsky Chairman
Christopher D. Brown Chief Technology Officer & Vice President
Mark D. Spoto Independent Director
Sector and Competitors
1st jan.Capi. (M$)
908 DEVICES INC.-56.89%685
SARTORIUS AG37.97%39 650
BIOTAGE AB (PUBL)88.49%1 794
REVENIO GROUP OYJ6.26%1 601
VAREX IMAGING CORPORATION69.48%1 131
CELLAVISION AB (PUBL)4.82%827